Home
ERIS.NS

Eris Lifesciences Limited

NSEHealthcare
₹1,427.00
-1.50%-₹21.70 today
₹0.00₹0.00
Ask Warren
Open
₹0.00
Prev close
₹1,448.70
Day range
₹0 – ₹0
52W range
₹1,200 – ₹1,885
Volume
26.1K
Avg vol (20D)
63.9K
Mkt cap
₹19,830.36Cr
P/E TTM
31.7×

Trade Eris Lifesciences Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Company Metrics

Revenue (ttm)₹3114.89 Cr
Net Income (ttm)₹0.00
Shares Out13.86 Cr
EPS (ttm)
Forward PE
Dividend
Ex-Dividend DateInvalid Date

Trading Metrics

Beta-0.11

About ERIS.NS

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees0
Stock ExchangeNSE
Ticker SymbolERIS.NS
ERIS.NS · NSE
Financial Performance

In 2026, Eris Lifesciences Limited's revenue was ₹3114.89 Cr, an increase of +7.10% compared to the previous year. Earnings were ₹0.00, an increase of +200.00%.

Revenue (2026)
₹3114.89 Cr
+7.10% YoY
Earnings (2026)
₹0.00
+200.00% YoY
Year-over-Year Growth
Revenue
+7.10%
Earnings
+200.00%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.